Given that substantially fewer AMPK-dKO cells still improved survival equivalently to WT cells, we reduced donor T cell numbers even further (0.1 × 106 cells/recipient) while maintaining 1 × 105 p815 GFP+ leukemia cells. This evidence concerns the gene PRKAA2 and leukemia.